Evaluation of an Innovative Information, Training and Social Support Intervention "INFOSADEM" to Principal Caregivers of Dementia Patients Living at Home
NCT ID: NCT04036955
Last Updated: 2019-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2016-03-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: A quasi-experimental study with repeated observations at 3 and 6 months post-intervention was performed. Intentional sampling and convenience assignment method was used for intervention and control groups. The intervention was structured developed at the beginning of the study, which consists of a multicomponent training, information and emotional support programme of five, 90-minute sessions over one week. The control group received Usual Care. The project was approved by the ethics committee (HCB/2014/0317) and follows the recommendations of the Declaration of Helsinki. Evidence gathered from our research will be published at national and international level.
Discussion: The results of this intervention will support other studies and contribute scientific evidence on the importance of promoting non-pharmacologic interventions in informal caregivers of people with dementia. At the same time, they can be used as the basis for the implementation of psycho educational interventions in home care and in long-term care institutions responsible for monitoring people with dementia; responding to training and information needs, and providing the social support that the caregivers themselves demand.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia
NCT04385797
"Living Together With Dementia"_Creation and Validation of a Training Program for Family Caregivers of People With Dementia to Live at Home
NCT03015428
Multicomponent Intervention in Caregivers on Quality of Life of People With Dementia: a Clinical Trial
NCT04280861
Effect of Individual Reminiscence Therapy in the Elderly People With Neurocognitive Disorders
NCT04658394
AIDMA: A Psycho-educational Program Designed to Support and Train Carers of Alzheimer's Disease (AD) Patients
NCT00190372
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Inclusion criteria
* People with a diagnose of dementia
* People older than 65 years old
* Living at home and receiving public formal care\* from Primary Health Care centers.
* Having an informal caregiver\*\* identified being capable of understand healthcare professional advices (this will be measured by healthcare professional criteria).
* Cognitive level having a MMSE score lower of 24 .
* Informed consent signed. \*We considered public formal care, the health care team working on Primary Care (being home care or primary care) (GPs,Registered Nurse, Social Worker).
* We considered informal caregiver the person (family or not) who takes care of the PwD and lives together or visit him/her at least three times a week.
Exclusion criteria
* People lower than 65 years old
* People with a psychiatric symptom or Korsakov sindrome
* People without informal caregiver identified
2. Outcome measures
* preparation for care through the Preparedness for Caregiving Scale (PCS)
* Perceived Competence Scale for Care
* Inventory Family needs
* Zarit Burden Scale
* Katz Index of Independence in Activities of Daily Living
* positive and negative aspects of care with the Caregiver Reaction assessment (CRA)
* Perceived Social Support Questionnaire (Duke-UNK )
* Quality of Life Scale (EQ-5D)
* General Health Questionnaire (GHQ-12)
* Resource Utilization Questionnaire for dementia (RUD)
* Neuropsychiatric Inventory (NPI) .
* Quality of Life in Alzheimer's Disease (QoL-AD)
* Charlson Comorbidity Index (CCI)
* Mini-Mental State Examination (MMSE)
* Global Deterioration Scale (GDS)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention group
The INFOSA-DEM programme consists of five, 90-minute informational/training sessions delivered consecutively over one week. Morning or afternoon groups are offered depending on the caregiver's availability. Programme content was developed for use in small groups of 6-8 caregivers. Topics covered in the sessions include basic concepts in dementia and specific issues such as nutrition, rest, medication, physical and cognitive changes, management of behavioural symptoms, affective problems in the patient and informal caregiver, verbal and non-verbal communication techniques, caregiver self-care and information on available resources and community services.
The sessions are conducted using audio-visual material to facilitate understanding of the content and to encourage active participation among caregivers when talking about their experiences.
INFOSA-DEM
Caregivers in the intervention group received the INFOSA-DEM programme, together with usual care provided by the participating centres, while caregivers in the CG received usual care in the centres where the follow-up was carried out.
usual care
Caregivers in the Group control received usual care in the centres where the follow-up was carried out. This consisted of annual or quarterly consultations with a health professional (GP, geriatrician or neurologist) and, depending on the health centre, a nurse and social worker.Currently, there is no homogenous protocol for all care centres for the patient with high levels of cognitive impairment and dependency.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
INFOSA-DEM
Caregivers in the intervention group received the INFOSA-DEM programme, together with usual care provided by the participating centres, while caregivers in the CG received usual care in the centres where the follow-up was carried out.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* People older than 65 years old
* Living at home and receiving public formal care\* from Primary Health Care centers.
* Having an informal caregiver\*\* identified being capable of understand healthcare professional advices (this will be measured by healthcare professional criteria).
* Cognitive level having a MMSE score lower of 24 .
* We considered public formal care, the health care team working on Primary Care (being home care or primary care) (GPs, Registered Nurse, Social Worker). \*\*We considered informal caregiver the person (family or not) who takes care of the PwD and lives together or visit him/her at least three times a week.
Exclusion Criteria
* People with a psychiatric symptom or Korsakov sindrome
* People without informal caregiver identified
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundació La Marató de TV3
OTHER
Hospital Clinic of Barcelona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adelaida Zabalegui Yarnoz
Adelaida Zabalegui Yarnoz
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HCB/2014/0317
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.